Zoetis Inc.: Form 10-Q for the period ended Jun 30, 2025
Filed with the SEC on Aug 5, 2025 and accepted by EDGAR at Aug 5, 2025, 13:58 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-04-01 to 2025-06-30 | $2.46bn | us-gaap:Revenues |
| Revenue | 6 months2025-01-01 to 2025-06-30 | $4.68bn | us-gaap:Revenues |
| Cost of revenue | 3 months2025-04-01 to 2025-06-30 | $649.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2025-01-01 to 2025-06-30 | $1.27bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2025-04-01 to 2025-06-30 | $617.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2025-01-01 to 2025-06-30 | $1.18bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months2025-04-01 to 2025-06-30 | $53.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2025-01-01 to 2025-06-30 | $107.0m | us-gaap:InterestExpense |
| Income tax | 3 months2025-04-01 to 2025-06-30 | $184.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2025-01-01 to 2025-06-30 | $363.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-04-01 to 2025-06-30 | $718.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2025-01-01 to 2025-06-30 | $1.35bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-04-01 to 2025-06-30 | $1.61 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2025-01-01 to 2025-06-30 | $3.02 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-04-01 to 2025-06-30 | $1.61 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2025-01-01 to 2025-06-30 | $3.02 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-04-01 to 2025-06-30 | 445,500,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2025-01-01 to 2025-06-30 | 446,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2025-01-01 to 2025-06-30 | $1.07bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2025-01-01 to 2025-06-30 | $327.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months2025-01-01 to 2025-06-30 | $781.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-06-30 | $1.44bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-06-30 | $5.92bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-06-30 | $14.48bn | us-gaap:Assets |
| Current liabilities | At period end2025-06-30 | $3.37bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-06-30 | $9.50bn | us-gaap:Liabilities |
| Long-term debt | At period end2025-06-30 | $5.23bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2025-06-30 | $1.35bn | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2025-06-30 | $0 | us-gaap:CommercialPaper |
| Shareholders' equity | At period end2025-06-30 | $4.98bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001555280-25-000261. Last ingested by Listed: Nov 5, 2026, 13:23 ET. Listed shows no prices and gives no investment advice.